Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) were down 0.4% during trading on Tuesday following insider selling activity. The stock traded as low as $563.85 and last traded at $571.10. Approximately 572,352 shares traded hands during mid-day trading, a decline of 70% from the average daily volume of 1,933,652 shares. The stock had previously closed at $573.48.
Specifically, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on the stock. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Evercore ISI upped their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday. CICC Research started coverage on Intuitive Surgical in a research note on Monday. They set a “neutral” rating and a $550.00 price objective for the company. Royal Bank of Canada raised their price target on Intuitive Surgical from $611.00 to $641.00 in a report on Monday. Finally, Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.
Intuitive Surgical Price Performance
The company has a 50 day moving average of $549.32 and a two-hundred day moving average of $507.50. The company has a market capitalization of $206.65 billion, a PE ratio of 93.28, a PEG ratio of 5.19 and a beta of 1.39.
Institutional Investors Weigh In On Intuitive Surgical
A number of institutional investors have recently modified their holdings of the stock. NewEdge Advisors LLC lifted its stake in Intuitive Surgical by 8.2% during the 2nd quarter. NewEdge Advisors LLC now owns 13,825 shares of the medical equipment provider’s stock valued at $6,150,000 after acquiring an additional 1,044 shares during the period. Northwestern Mutual Wealth Management Co. raised its stake in Intuitive Surgical by 2.1% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 20,458 shares of the medical equipment provider’s stock valued at $9,100,000 after buying an additional 411 shares during the last quarter. Quarry LP lifted its holdings in shares of Intuitive Surgical by 134.7% during the 2nd quarter. Quarry LP now owns 115 shares of the medical equipment provider’s stock valued at $51,000 after buying an additional 66 shares during the period. Advisory Alpha LLC boosted its stake in shares of Intuitive Surgical by 36.5% in the 2nd quarter. Advisory Alpha LLC now owns 1,417 shares of the medical equipment provider’s stock worth $630,000 after buying an additional 379 shares during the last quarter. Finally, New Century Financial Group LLC purchased a new stake in Intuitive Surgical during the second quarter valued at $251,000. 83.64% of the stock is owned by hedge funds and other institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- How Investors Can Find the Best Cheap Dividend Stocks
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Roth IRA Calculator: Calculate Your Potential Returns
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- What is Insider Trading? What You Can Learn from Insider Trading
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.